These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10357195)

  • 1. Rhabdomyolysis due to bezafibrate in CAPD patients. A role for dihydropyridine drugs?
    Weissgarten J; Zaidenstein R; Fishman S; Dishi V; Michovitz-Koren M; Averbukh Z; Golik A
    Perit Dial Int; 1999; 19(2):180-2. PubMed ID: 10357195
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient.
    Panuccio V; Enia G; Parlongo S; Cutrupi S; Zoccali C
    Nephron; 1996; 73(4):736. PubMed ID: 8856294
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone scintigraphy of drug-induced rhabdomyolysis: antihyperlipidemia agent.
    Takayama T; Tsuji S; Taki J; Michigishi T; Tonami N
    Clin Nucl Med; 1996 Dec; 21(12):988-9. PubMed ID: 8957627
    [No Abstract]   [Full Text] [Related]  

  • 4. Rhabdomyolysis and acute renal failure associated with bezafibrate treatment.
    Górriz JL; Sancho A; Alcoy E; García-Ramos JL; Pallardó LM
    Nephrol Dial Transplant; 1995 Dec; 10(12):2371-2. PubMed ID: 8808248
    [No Abstract]   [Full Text] [Related]  

  • 5. Mizoribine-induced rhabdomyolysis in a rheumatoid arthritis patient receiving bezafibrate treatment.
    Morimoto S; Fujioka Y; Tsutsumi C; Masai M; Okumura T; Yuba M; Sakoda T; Tsujino T; Ohyanagi M
    Am J Med Sci; 2005 Apr; 329(4):211-3. PubMed ID: 15832106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute rhabdomyolysis after bezafibrate re-exposure.
    Terrovitou CT; Milionis HJ; Elisaf MS
    Nephron; 1998; 78(3):336-7. PubMed ID: 9546698
    [No Abstract]   [Full Text] [Related]  

  • 7. Stevens-Johnson syndrome associated with bezafibrate.
    Sawamura D; Umeki K
    Acta Derm Venereol; 2000; 80(6):457. PubMed ID: 11243650
    [No Abstract]   [Full Text] [Related]  

  • 8. Rhabdomyolysis with HMG CoA reductase inhibitors: a class effect?
    Langford NJ; Kendall MJ
    J Clin Pharm Ther; 2001 Dec; 26(6):391-5. PubMed ID: 11722675
    [No Abstract]   [Full Text] [Related]  

  • 9. Influenza vaccine--a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate.
    Plotkin E; Bernheim J; Ben-Chetrit S; Mor A; Korzets Z
    Nephrol Dial Transplant; 2000 May; 15(5):740-1. PubMed ID: 10809833
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rhabdomyolysis and acute renal failure secondary to statins].
    Borrego FJ; Liébana A; Borrego J; Pérez del Barrio P; Gil JM; García Cortés MJ; Sánchez Perales C; Serrano P; Pérez Bañasco V
    Nefrologia; 2001; 21(3):309-13. PubMed ID: 11471312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute rhabdomyolysis and hemoglobin reduction after bezafibrate overdose in hyperlipidemic patients on hemodialysis.
    Bedani PL; Perini L; Gilli P
    Nephron; 1994; 68(4):512-3. PubMed ID: 7870241
    [No Abstract]   [Full Text] [Related]  

  • 12. Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole.
    Maxa JL; Melton LB; Ogu CC; Sills MN; Limanni A
    Ann Pharmacother; 2002 May; 36(5):820-3. PubMed ID: 11978159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin potentiation with bezafibrate.
    Beringer TR
    Postgrad Med J; 1997 Oct; 73(864):657-8. PubMed ID: 9497982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of creatine kinase elevation during treatment with fluvastatin in combination with fibrates (bezafibrate, fenofibrate, or gemfibrozil).
    Farnier M; Bortolini M; Salko T; Freudenreich MO; Isaacsohn JL; Troendle AJ; Gonasun L
    Am J Cardiol; 2003 Jan; 91(2):238-40. PubMed ID: 12521642
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bezafibrate-induced rhabdomyolysis in a patient with impaired kidney function].
    Haubenstock A; Schmidt P; Zazgornik J; Balcke P; Kopsa H; Sertl K
    Dtsch Med Wochenschr; 1984 Jan; 109(4):157-8. PubMed ID: 6692783
    [No Abstract]   [Full Text] [Related]  

  • 16. Fenofibrate-induced rhabdomyolysis in two dialysis patients with hypothyroidism.
    Clouâtre Y; Leblanc M; Ouimet D; Pichette V
    Nephrol Dial Transplant; 1999 Apr; 14(4):1047-8. PubMed ID: 10328516
    [No Abstract]   [Full Text] [Related]  

  • 17. Rhabdomyolysis with simvastatin and nefazodone.
    Thompson M; Samuels S
    Am J Psychiatry; 2002 Sep; 159(9):1607. PubMed ID: 12202291
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD.
    Yang KC; Fang CC; Su TC; Lee YT
    Am J Kidney Dis; 2005 Mar; 45(3):e57-60. PubMed ID: 15754265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bezafibrate myopathy in two patients with chronic renal failure].
    Inoue M; Jimi T; Machida H; Niwa Y; Wakayama Y
    Rinsho Shinkeigaku; 1992 Jul; 32(7):725-8. PubMed ID: 1291164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should hyperlipidaemia in dialysis patients be treated?
    Wheeler DC
    Nephrol Dial Transplant; 1997 Jan; 12(1):19-21. PubMed ID: 9027766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.